Application of β-galactosidase enzyme complementation technology as a high throughput screening format for antagonists of the epidermal growth factor receptor

Journal of Biomolecular Screening

Volumn 6, Issue 6, 2001, Pages 401-411

  Graham, Debbie L ^a   Bevan, Nicola ^a   Lowe, Peter N ^a   Palmer, Michelle ^b   Rees, Stephen ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Applied Biosystems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CHIMERIC PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY;

ANIMAL CELL; ARTICLE; CELL LINE; CHEMOLUMINESCENCE; DELETION MUTANT; DIMERIZATION; ESCHERICHIA COLI; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SCREENING TEST;

ANIMALS; BETA-GALACTOSIDASE; CELL LINE; CHEMILUMINESCENT MEASUREMENTS; DIMERIZATION; DIMETHYL SULFOXIDE; ESCHERICHIA COLI; GENETIC COMPLEMENTATION TEST; RECEPTOR, EPIDERMAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY;

ANIMALIA; ESCHERICHIA COLI; MAMMALIA;

EID: 0035675336     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1089/108705701753364896     Document Type: Article

References (32)

1. Orphan G-protein coupled receptors; The next generation of drug targets?
2. Voltage-gated sodium channels as therapeutic targets
3. Novel anticancer drug discovery
4. 2+ using the fluorometric imaging plate reader (FLIPR)
5. Transcriptional regulation by extracellular signals: Mechanisms and specificity
6. Reporter gene systems for the study of G-protein coupled receptor signalling in mammalian cells
7. Development of a facile method for high throughput screening with reporter gene assays
8. Cell based versus isolated target screening - How lucky do you feel?
9. Monitoring protein-protein interactions in intact eukaryotic cells by β-galactosidase complementation
10. Epidermal growth factor receptor dimerization monitored in live cells
11. Oligomerization domain-directed reassembly of active reductase from rationally designed fragments
12. Erythropoietin receptor activation by a ligand-induced conformational change
13. Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays
14. An in vivo library-versus-library selection of optimised protein-protein interactions
15. Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: Role as anticancer agents
16. The epidermal growth factor receptor and its ligand family: Their potential role in repair and remodelling in asthma
17. The role of the epidermal growth factor receptor in infections of the gastrointestinal tract
18. The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinases
19. A simple statistical parameter for use in evaluation and validation of high throughput screening assays
20. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities
21. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity
22. The β-adrenoceptor
23. Structure-function studies of ligand-induced epidermal growth factor receptor dimerization
24. Superagonistic activation of ErbB-1 by EGF-related growth factors with enhanced association and dissociation rate constants
25. Development of a homogeneous MAP kinase reporter gene screen for the identification of agonists and antagonists at the CXCR1 chemokine receptor
26. A β-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation
27. Using GFP in FRET-based applications
28. Fluorescent protein biosensors: New tools for drug discovery
29. A bioluminescence resonance energy transfer (BRET) system: Application to interacting circadian clock proteins
30. Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)
31. Chemiluminescent reporter gene assays with 1,2-dioxetane enzyme substrates
32. Characterisation of NFκB activation by detection of green fluorescent protein-tagged IκB degradation in living cells